ZA201007611B - Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamine - Google Patents
Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamineInfo
- Publication number
- ZA201007611B ZA201007611B ZA2010/07611A ZA201007611A ZA201007611B ZA 201007611 B ZA201007611 B ZA 201007611B ZA 2010/07611 A ZA2010/07611 A ZA 2010/07611A ZA 201007611 A ZA201007611 A ZA 201007611A ZA 201007611 B ZA201007611 B ZA 201007611B
- Authority
- ZA
- South Africa
- Prior art keywords
- methylsulfamine
- sulfamates
- benzodioxin
- benzo
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/058233 WO2009120191A1 (en) | 2008-03-26 | 2008-03-26 | Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201007611B true ZA201007611B (en) | 2012-04-25 |
Family
ID=40030223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2010/07611A ZA201007611B (en) | 2008-03-26 | 2010-10-25 | Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamine |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2280950A1 (en) |
JP (1) | JP2011515464A (en) |
KR (1) | KR20100126535A (en) |
CN (1) | CN101981019A (en) |
AU (1) | AU2008353491A1 (en) |
BR (1) | BRPI0822454A2 (en) |
CA (1) | CA2719624A1 (en) |
CR (1) | CR11761A (en) |
EA (1) | EA201071120A1 (en) |
EC (1) | ECSP10010499A (en) |
IL (1) | IL208222A0 (en) |
MX (1) | MX2010010595A (en) |
WO (1) | WO2009120191A1 (en) |
ZA (1) | ZA201007611B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
AU2006249577A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
JP2009537635A (en) | 2006-05-19 | 2009-10-29 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Co-therapy for treatment of hemorrhoids |
CA2729056A1 (en) * | 2008-06-23 | 2010-01-21 | Janssen Pharmaceutica Nv | Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN107954906B (en) * | 2017-11-24 | 2020-10-16 | 西北师范大学 | Synthetic method of aryl sulfonyl tertiary amine compound |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
AR049646A1 (en) * | 2004-06-16 | 2006-08-23 | Janssen Pharmaceutica Nv | USEFUL SULFAMATE AND SULFAMIDE DERIVATIVES FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS |
JP4912312B2 (en) * | 2004-08-24 | 2012-04-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Novel benzo-fused heteroarylsulfamide derivatives useful as anticonvulsants |
TW200738669A (en) * | 2006-02-22 | 2007-10-16 | Janssen Pharmaceutica Nv | Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide |
-
2008
- 2008-03-26 EA EA201071120A patent/EA201071120A1/en unknown
- 2008-03-26 MX MX2010010595A patent/MX2010010595A/en unknown
- 2008-03-26 JP JP2011501761A patent/JP2011515464A/en not_active Withdrawn
- 2008-03-26 AU AU2008353491A patent/AU2008353491A1/en not_active Abandoned
- 2008-03-26 BR BRPI0822454-4A patent/BRPI0822454A2/en not_active IP Right Cessation
- 2008-03-26 WO PCT/US2008/058233 patent/WO2009120191A1/en active Application Filing
- 2008-03-26 KR KR1020107023447A patent/KR20100126535A/en not_active Application Discontinuation
- 2008-03-26 CN CN2008801285434A patent/CN101981019A/en active Pending
- 2008-03-26 CA CA2719624A patent/CA2719624A1/en not_active Abandoned
- 2008-03-26 EP EP08744381A patent/EP2280950A1/en not_active Withdrawn
-
2010
- 2010-09-19 IL IL208222A patent/IL208222A0/en unknown
- 2010-09-24 EC EC2010010499A patent/ECSP10010499A/en unknown
- 2010-10-25 ZA ZA2010/07611A patent/ZA201007611B/en unknown
- 2010-10-26 CR CR11761A patent/CR11761A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2008353491A1 (en) | 2009-10-01 |
BRPI0822454A2 (en) | 2015-06-16 |
EA201071120A1 (en) | 2011-06-30 |
WO2009120191A1 (en) | 2009-10-01 |
CN101981019A (en) | 2011-02-23 |
CA2719624A1 (en) | 2009-10-01 |
MX2010010595A (en) | 2010-10-25 |
EP2280950A1 (en) | 2011-02-09 |
ECSP10010499A (en) | 2010-10-30 |
JP2011515464A (en) | 2011-05-19 |
IL208222A0 (en) | 2010-12-30 |
CR11761A (en) | 2011-07-06 |
KR20100126535A (en) | 2010-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201007611B (en) | Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamine | |
IL229239A0 (en) | Crystalline forms of dimethoxy docetaxel and methods for preparing the same | |
HK1141013A1 (en) | Process for the preparation of certain substituted sulfilimines | |
EP2305667A3 (en) | Nilotinib intermediates and preparation thereof | |
WO2010014883A3 (en) | Azacitidine process and polymorphs | |
ZA200806799B (en) | Novel pyrone-indole derivatives and process for their preparation | |
BR112012012106A2 (en) | '' Tasty granulated food concentrate, process for producing a granular flavourous food concentrate and use of a food concentrate | |
EP2329823A4 (en) | Method for improving absorbability of preparation, and preparation having improved absorbability | |
EP2038282A4 (en) | Salts of pyrrolopyrimidinone derivatives and process for preparing the same | |
IL193089A0 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
PL1989182T3 (en) | Crystalline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it | |
AU2009254929A8 (en) | An improved process for the preparation of amines | |
EP2155709A4 (en) | Stable anhydrous crystalline docetaxel and method for the preparation thereof | |
ZA201600550B (en) | Compositions, methods and uses for inducing viral growth | |
ZA201100016B (en) | "crystal of spiroketal derivatives and process for preparation of spiroketal derivatives" | |
EP2361907A4 (en) | The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof | |
PL2102174T3 (en) | Process for the preparation of substituted cynophenoxy-pyrimidinyloxy-phenyl acrylate derivatives | |
EP2083003A4 (en) | Process for preparation of 1,1,1,3,3-pentachlorobutane | |
EP2251337A4 (en) | Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof | |
IL212850A0 (en) | Novel method for the preparation of granulates of active constituents, and granulates as obtained | |
GB0601684D0 (en) | Composition, process for preparation and method of use | |
PL2501821T3 (en) | Process for producing primycin, primycin component(s), precursors and metabolites thereof via fementation by the use of bacterial species saccharomonospora azurea | |
EP2222624A4 (en) | Derivatives of 4-nerolidylcatechol, pharmaceutical compositions comprising them and process for producing the same | |
PL2473492T3 (en) | Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes | |
ZA201004272B (en) | An improved process for the preparation of trans 3,4-diarylchroman and their derivatives |